History

Dexela was founded in 2005 to undertake the commercialisation of tomosynthesis for breast cancer screening and other low dose medical x-ray imaging applications. The company is building a portfolio of intellectual property in this field and is a leader in the core imaging geometry IPR, computational techniques for image reconstruction and viewing workstations for tomosynthesis. Dexela has developed two products implementing this IPR:

• Tomosynthesis reconstruction software


• DexTop breast imaging diagnostic review workstation

In May 2006 the company closed its first round of financing led by Close Ventures, raising £1.6 million.

In 2006 Dexela secured XCounter, a Swedish tomosynthesis company, as its first OEM customer.

In 2008 the company launched DexTop, a powerful mammography screening workstation with tomosynthesis features built in.

In January 2008 Dexela acquired Aviex LLC, a business that designs and builds high performance X-ray detectors for scientific applications. The know-how of the Aviex group in combination with Dexela’s software expertise has positioined Dexela to include X-ray detector technology as part of its future programme.

In July 2008 the company closed a second round of financing with Close Ventures and London Technology Fund raising £2.6 million.

In November 2008 Dexela expanded its operations and moved to a new facility in central London.

Dexela Business Model

The combination of complementary technologies and relevant experience uniquely position Dexela to target OEM vendors across multiple market segments by adding value and differentiation for applications requiring fast, low dose, X-ray imaging.

The company offers combinations of technology licencing, supply of sub-systems or components with professional services leveraging experience and know how in this highly specialized area.